Diagnostics

Clinical trials offer pathologists the opportunity to work at the forefront of diagnostic discovery

Researchers have taken a proteomic approach to identifying biomarkers associated with higher mortality in Staphylococcus aureus bacteremia

SARS-CoV-2 antibody tests are still not widely available – is it time for a different approach?

When it comes to cancer or infectious disease diagnosis, could we simply exhale the answers?

From highly sensitive SARS-CoV-2 tests to RNA purification kits, discover what’s new in business this week

Phf21b, a protein associated with intellectual disability and depression, plays a crucial role in neurogenesis

What can our approach to screening newborns for disease teach us about testing for COVID-19?

A timeline of key molecular pathology events, from Sanger sequencing to 100,000 genomes

What’s new in the world of pathology and laboratory medicine? We offer a rapid roundup of recent research

Exhaled particles are of greater interest than ever – so how can we turn them to our advantage for disease diagnosis?